Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice: ANP for pulmonary fibrosis

BACKGROUND: Pulmonary fibrosis is a life-threatening disease characterized by progressive dyspnea and worsening pulmonary function. Atrial natriuretic peptide (ANP), a heart-derived secretory peptide used clinically in Japan for the treatment of acute heart failure, exerts a wide range of protective...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Atsuko, Nojiri, Takashi, Konishi, Kazuhisa, Tokudome, Takeshi, Miura, Koichi, Hosoda, Hiroshi, Hino, Jun, Miyazato, Mikiya, Kyomoto, Yohkoh, Asai, Kazuhisa, Hirata, Kazuto, Kangawa, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210263/
https://www.ncbi.nlm.nih.gov/pubmed/28049526
http://dx.doi.org/10.1186/s12931-016-0492-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210263/
https://www.ncbi.nlm.nih.gov/pubmed/28049526
http://dx.doi.org/10.1186/s12931-016-0492-7

Ejemplares similares